Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Return on Capital %

Rigel Pharmaceuticals Return on Capital % Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Return on Capital % from 2010 to 2020.
  • Rigel Pharmaceuticals Return on Capital % for the quarter ending June 06, 2020 was -39.57 a 29.43% decrease of -11.65 year over year
  • Rigel Pharmaceuticals Return on Capital % for the last 12 months ending June 06, 2020 was -14.98 a -94.96% increase of 14.23 year over year
  • Rigel Pharmaceuticals Annual Return on Capital % for 2019 was -43.18 a 0.06% decrease of -0.02 from 2018
  • Rigel Pharmaceuticals Annual Return on Capital % for 2018 was -43.16 a -48.13% increase of 20.77 from 2017
  • Rigel Pharmaceuticals Annual Return on Capital % for 2017 was -63.93 a 14.57% decrease of -9.31 from 2016
Other Margins & Efficiency Metrics:
  • Rigel Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $7m a 801.93% increase of 57m year over year
  • Rigel Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -83.74 a -57.61% increase of 48.24 year over year
View Chart On Koyfin

Quarterly RIGL Return on Capital % Data

06/2020-39.57
03/202051.65
12/2019-43.94
09/2019-27.93
06/2019-45.32
03/2019-38.79
12/20185.93
09/2018-53.67
06/2018-64.19
03/2018-68.53

Annual RIGL Return on Capital % Data

2019-43.18
2018-43.16
2017-63.93
2016-54.62
2015-29.45
2014-33.90
2013-22.06
2012-23.65
2011-26.78
201015.84